Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update
The purpose of this work was to evaluate the suitability of recent US Food and Drug Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products for children in North America, to identify the next group of Active Pharmaceutical Ingredients (APIs) that have high potential fo...
Main Authors: | Richard H. Parrish, Lisa D. Ashworth, Raimar Löbenberg, Sandra Benavides, Jeffrey J. Cies, Robert B. MacArthur |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/5/1032 |
Similar Items
-
Pharmaceutical errors while manufacturing medicines in pharmacies
by: S.S. Malchenkova, et al.
Published: (2022-12-01) -
An Algorithm to Identify Compounded Non-Sterile Products that Can Be Formulated on a Commercial Scale or Imported to Promote Safer Medication Use in Children
by: Varsha Bhatt-Mehta, et al.
Published: (2015-11-01) -
Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance
by: Olga González-González, et al.
Published: (2023-05-01) -
Prevalence, Scope and Quality of Extemporaneous Medications in Selected Healthcare Facilities and Implications for Pharmacy Practice
by: Grace Lovia Allotey-Babington, et al.
Published: (2024-04-01) -
Drug Stability: ICH versus Accelerated Predictive Stability Studies
by: Olga González-González, et al.
Published: (2022-10-01)